Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects.
Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy.
- Presents the progress made in cancer medicines from conventional to targeted therapy
- Covers the present state-of-the-art of cancer nanomedicines and upcoming therapeutic cancer vaccination
- Contains a focus on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, siRNA
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
Dateigröße
ISBN-13
978-0-12-823687-1 (9780128236871)
Schweitzer Klassifikation
1. Cancer vaccines: Past, present and future2. Inorganic Nanoparticulate Carriers in management of Cancer: Theranostic and Toxicity Apprehension3. Recent developments in cancer vaccines: Where are we?4. Application of Nanotechnology assisted devices in cancer treatment5. Protein Based Nanocarriers as a Potent Drug Delivery Vehicle for Cancer Therapy6. Nanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapy7. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies8. Peptide based anticancer targeted therapeutics: State of the Art9. Polyplexes-based delivery systems for cancer vaccine delivery10. Lipopolyplexes-based delivery system for cancer vaccine delivery11. Inorganic nanoparticulate carriers in cancer vaccination12. Functional nanomaterials and nanocomposites in cancer vaccines13. DNA vaccines for cancer treatment: Challenges and promises14. mRNA-based nanovaccines as newer treatment modalities in cancer15. Cancer immunotherapy: Moving forward with peptide T cell vaccines16. Product development and scale-up challenges in cancer vaccine development17. Regulatory landscape in the approval of cancer vaccines18. Cross-Presentation-based Nanovaccine for Cancer Immunotherapy19. Immunotherapy based cancer Vaccines: State of the art20. Therapeutics peptides in Anticancer therapy21. Inorganic Nanoconjugates For Cancer Theragnosis
